top of page

December 12, 2022

The ASCO Post: How the Pancreatic Cancer Early Detection Consortium Aims to Advance Survival Rates in This Deadly Disease

Read more from 


December 7th - 8th, 2022

2022 PRECEDE Annual Meeting and Biomarker Summit 


September 14, 2022

“Great meeting at the 2022 AACR Pancreatic Cancer meeting in Boston!”



From left to right: A. Orlacchio, E. Kawaler, A. Ackermann, G. Oh, S. Dhara, D. Simeone and G. Tamas

Oral Presentations:
Primary results of PanCAN-SR1, a phase 1b study evaluating Gemcitabine, nab-Paclitaxel, Canakinumab, and Spartalizumabto target IL-1β and PD-1 in metastatic pancreatic cancer with correlative tissue and blood biomarker analysis by Paul Oberstein, MD
Single-cell sequencing elucidates the effects of chemotherapy on cancer cell heterogeneity and the tumor microenvironment of human pancreatic adenocarcinoma by Emily Kawaler, PhD and Daniel Weissinger, MD 
Poster Presentations:
Polymerase theta inhibition activates the cGAS-STING signaling pathway and elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma by Grace Oh, MD

July 22, 2022

What an amazing honor @pancreasfest! So proud of our highly collaborative community in supporting the important work we are doing for pancreatic cancer! #PancreaticCancer



February 4, 2022

The future looks brighter for pancreatic cancer patients and families as we celebrate World Cancer Day! #PRECEDE

DS Research Lab PRECEDE Group Pic.jpg

November 18, 2021

On World Pancreatic Cancer Day, we’d like to acknowledge and thank all those who are dedicated to pancreatic cancer early detection, treatment and research.

bottom of page